alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer.
Ivanov O; Chen F; Wiley EL; Keswani A; Diaz LK; Memmel HC; Rademaker A; Gradishar WJ; Morrow M; Khan SA; Cryns VL; Breast Cancer Research And Treatment, 2008, vol. 111, issue 3, p 411, ISSN 01676806. ISBN 01676806.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef